Enliven Therapeutics, Inc.
ELVN
Revenue
0.00
0.000.00%
-Assets
476.17M
▼-14.71M▼-3.00%
3 Months ChangeLiabilities
16.57M
▲1.82M▲12.30%
3 Months ChangeFree Cash Flow
-24.15M
▼-766.00k▼-3.28%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001193125-26-088195
2026-01-07
Form 8-K
ID: 0001193125-26-005535
2025-12-11
Form 8-K
ID: 0001193125-25-315196
2025-11-12
Form 10-Q
ID: 0001193125-25-277619
2025-11-12
Form 8-K
ID: 0001193125-25-277580
2025-08-13
Form 10-Q
ID: 0001193125-25-179845
2025-08-13
Form 8-K
ID: 0001193125-25-179837
2025-06-25
Form 8-K
ID: 0001193125-25-146874
2025-06-16
Form 8-K
ID: 0001193125-25-141085
2025-06-13
Form 8-K
ID: 0001193125-25-140285